Theranexus
Clinical-stage biopharmaceutical company developing treatments for rare neurological disorders.
ALTHX | PA
Overview
Corporate Details
- ISIN(s):
- FR0013286259
- LEI:
- 969500BFCV6IC7MFQP20
- Country:
- France
- Address:
- 60 AVENUE ROCKEFELLER, 69008 LYON
- Website:
- https://www.theranexus.com/en/
- Sector:
- Manufacturing
Description
THX Pharma (formerly Theranexus) is an innovative, clinical-stage biopharmaceutical company that emerged from the French Alternative Energies and Atomic Energy Commission (CEA). The company specializes in developing treatments for rare neurological disorders. It leverages a unique platform for the identification and characterization of advanced therapy drug candidates. Its lead program is a drug candidate in clinical development for Batten disease, a rare neurodegenerative disorder.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-10-01 18:00 |
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS C…
|
French | 278.5 KB | ||
| 2021-09-30 18:00 |
RAPPORT SEMESTRIEL 2021
|
French | 10.1 MB | ||
| 2021-09-30 18:00 |
THERANEXUS ANNOUNCES ITS FIRST HALF 2021 RESULTS
|
English | 497.0 KB | ||
| 2021-09-30 18:00 |
THERANEXUS ANNONCE SES RÉSULTATS DU PREMIER SEMESTRE 2021
|
French | 1.4 MB | ||
| 2021-09-21 18:00 |
Publication mensuelle du nombre d'actions composant le capital et du nombre tot…
|
French | 276.5 KB | ||
| 2021-09-09 18:00 |
THERANEXUS ET LA FONDATION BEYOND BATTEN DISEASE (BBDF) OBTIENNENT LE STATUT D'…
|
French | 756.4 KB | ||
| 2021-09-09 18:00 |
THERANEXUS AND BEYOND BATTEN DISEASE FOUNDATION (BBDF) WIN US INVESTIGATIONAL N…
|
English | 477.2 KB | ||
| 2021-08-03 18:00 |
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS C…
|
French | 278.6 KB | ||
| 2021-07-28 18:00 |
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS C…
|
French | 278.1 KB | ||
| 2021-07-08 18:00 |
THERANEXUS PUBLISHES ITS CASH POSITION AS OF 30 JUNE 2021 AND PRESENTS AN UPDAT…
|
English | 1.5 MB | ||
| 2021-07-08 18:00 |
THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 30 JUIN 2021 ET FAIT UN POINT SU…
|
French | 1.6 MB | ||
| 2021-07-06 18:00 |
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE - 1ER SEMESTRE 2021
|
French | 370.7 KB | ||
| 2021-06-23 18:00 |
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS C…
|
French | 275.2 KB | ||
| 2021-06-16 18:00 |
MINUTES OF THE COMBINED GENERAL MEETING OF 16 JUNE 2021
|
English | 177.6 KB | ||
| 2021-06-16 18:00 |
COMPTE-RENDU DE L'ASSEMBLÉE GÉNÉRALE MIXTE DU 16 JUIN 2021
|
French | 226.6 KB |
Automate Your Workflow. Get a real-time feed of all Theranexus filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Theranexus
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Theranexus via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
